Admission neutrophil-lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy

Journal of NeuroInterventional Surgery

Volumn 6, Issue 8, 2014, Pages 578-583

  Brooks, Steven D ^a,b   Spears, Chauncey ^a,b   Cummings, Christopher ^a,c   VanGilder, Reyna L ^a,b   Stinehart, Kyle R ^a   Gutmann, Laurie ^a,c   Domico, Jennifer ^c   Culp, Stacey ^b   Carpenter, Jeffrey ^a,c   Rai, Ansaar ^a,c   Barr, Taura L ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BIOLOGICAL MARKER; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENDOVASCULAR SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE DIFFERENTIAL COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NEUTROPHIL LYMPHOCYTE RATIO; POST HOC ANALYSIS; PREDICTION; PROGNOSIS; RANKIN SCALE; RECANALIZATION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; STUDENT T TEST; THROMBOLYSIS IN MYOCARDIAL INFARCTION; TREATMENT OUTCOME; UNITED STATES; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL; VERY ELDERLY; ADOLESCENT; BLOOD; FIBRINOLYTIC THERAPY; LEUKOCYTE COUNT; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; PROCEDURES; SEVERITY OF ILLNESS INDEX; STROKE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906997576     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-010780     Document Type: Article

References (23)

1. Meyers PM, Schumacher HC, Connolly ES Jr., et al. Current status of endovascular stroke treatment. Circulation 2011;123:2591-601.
2. Ghobrial GM, Chalouhi N, Rivers L, et al. Multimodal endovascular management of acute ischemic stroke in patients over 75 years old is safe and effective. J Neurointerv Surg 2013;5(Suppl 1):i33-i37.
3. Walsh SR, Cook EJ, Goulder F, et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181-4.
4. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102:5-14.
5. Tokgoz S, Kayrak M, Akpinar Z, et al. Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis Published Online First Mar 2013. pii: S1052-3057(13)00017-7. doi:10.1016/j.jstrokecerebrovasdis.2013.01.011
6. Poisson SN, Johnston SC, Josephson SA. Urinary tract infections complicating stroke: mechanisms, consequences, and possible solutions. Stroke 2010;41:e180-4.
7. Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003;198:725-36.
8. Rai AT, Jhadhav Y, Domico J, et al. Procedural predictors of outcome in patients undergoing endovascular therapy for acute ischemic stroke. Cardiovasc Intervent Radiol 2012;35:1332-9.
9. Tamhane UU, Aneja S, Montgomery D, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102:653-7.
10. de Jager CP, van Wijk PT, Mathoera RB, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 2010;14:R192.
11. Kaya H, Ertas F, Islamoglu Y, et al. Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clin Appl Thromb Hemost Published Online First: 7 Aug 2013. doi:10.1177/1076029613499821
12. Buyukkaya E, Karakas MF, Karakas E, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost Published Online First: 18 Sept 2013. doi:10.1177/1076029612459675
13. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893-903.
14. Yoo AJ, Chaudhry ZA, Nogueira RG, et al. Infarct volume is a pivotal biomarker after intra-Arterial stroke therapy. Stroke 2012;43:1323-30.
15. Harris NR, Rumbaut RE. Age-related responses of the microcirculation to ischemia-reperfusion and inflammation. Pathophysiology 2001;8:1-10.
16. Davenport RJ, Dennis MS, Wellwood I, et al. Complications after acute stroke. Stroke 1996;27:415-20.
17. Meisel C, Schwab JM, Prass K, et al. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005;6:775-86.
18. Elkind MS, Cheng J, Rundek T, et al. Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study. J Stroke Cerebrovasc Dis 2004;13:220-7.
19. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011;17:796-808.
20. Jickling GC, Sharp FR. Blood biomarkers of ischemic stroke. Neurotherapeutics 2011;8:349-60.
21. Deguchi T, Takeshita N, Balam TA, et al. Galanin-immunoreactive nerve fibers in the periodontal ligament during experimental tooth movement. J Dent Res 2003;82:677-81.
22. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009;158:1098-111.
23. Nardi K, Milia P, Eusebi P, et al. Admission leukocytosis in acute cerebral ischemia: influence on early Outcome. J Stroke Cerebrovasc Dis 2012;21:819-24.